Ingredient

Decafluoropentane

Decafluoropentane is flagged for pregnancy, breastfeeding and trying to conceive. The concern behind the strongest flag is absorbed into the body and fetal development.

By Team TruvaLast checked

Verdict by profile

Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.

Strongest verdict
Caution Advised
Its verdict for pregnancy, the profile this one is worst in
Profiles flagged
3 of 6
Counting avoid, high risk and medium risk
Last checked
15 September 2026
The day this assessment was read from the catalogue
PregnancyCAUTION

Decafluoropentane and pregnancy

Caution Advised

Decafluoropentane is a perfluorinated compound (PFC) used as a solvent and propellant in cosmetic aerosols and certain skincare products. It helps deliver active ingredients and creates light textures in formulations. While specific studies on topical decafluoropentane during pregnancy are lacking, research on PFCs as a class has shown they can cross the placental barrier and accumulate in fetal tissues. Studies published in Environmental Health Perspectives have linked prenatal PFC exposure to lower birth weight and potential developmental effects. The lipophilic nature of these compounds means they can be absorbed through skin and accumulate over time, though the extent of absorption from cosmetic use is not well-characterized. No regulatory body has issued specific guidance on decafluoropentane in cosmetics during pregnancy. However, given the concerns about PFC bioaccumulation and the precautionary principle recommended by ACOG for chemicals with uncertain fetal effects, many healthcare providers suggest limiting exposure to perfluorinated compounds when possible during pregnancy. The limited safety data and known persistence of PFCs support a cautious approach.

BreastfeedingCAUTION

Decafluoropentane and breastfeeding

Caution Advised

As a perfluorinated compound, decafluoropentane is highly lipophilic and persistent, raising concerns about transfer to breast milk. Research on PFCs has demonstrated that these compounds can accumulate in breast milk due to their fat-soluble nature and resistance to breakdown. Studies in Environmental Science & Technology have detected various PFCs in human breast milk samples, suggesting that maternal exposure can lead to infant exposure through breastfeeding. While specific data on decafluoropentane from cosmetic use is not available, the chemical properties of PFCs as a class indicate potential for transfer and accumulation. The AAD notes that minimizing exposure to persistent environmental chemicals during lactation is a reasonable precaution. Given the lack of specific safety data and the known behavior of perfluorinated compounds, many dermatologists and lactation consultants suggest avoiding products containing PFCs during breastfeeding when safer alternatives are available. The persistent nature and potential for bioaccumulation make this a prudent choice despite the limited direct evidence.

PostpartumSAFE

Decafluoropentane and postpartum

Safe to Use

For postpartum women who are not breastfeeding, decafluoropentane presents primarily environmental concerns rather than direct health risks from typical cosmetic use. The ingredient functions effectively as a solvent and propellant without significant skin irritation. While PFCs raise environmental and long-term bioaccumulation concerns, the immediate health risks from topical cosmetic use in non-pregnant, non-breastfeeding adults are considered low based on current evidence. Standard cosmetic use involves limited exposure and absorption compared to dietary or occupational exposure routes.

Trying to ConceiveCAUTION

Decafluoropentane and trying to conceive

Caution Advised

Women trying to conceive may want to minimize exposure to perfluorinated compounds due to their persistence and potential bioaccumulation. Some research has suggested associations between PFC exposure and delayed conception, though specific evidence for decafluoropentane from cosmetic use is lacking. The precautionary approach recommended for pregnancy extends to the preconception period, as PFCs can accumulate in body tissues over time. Reducing exposure before conception may lower body burden and subsequent fetal exposure. While the direct fertility impact of topical cosmetic use is unclear, limiting PFC exposure is a reasonable precaution for women actively trying to conceive.

PCOSSAFE

Decafluoropentane and PCOS

Safe to Use

Decafluoropentane functions as a solvent in cosmetic formulations without direct hormonal activity. There is no evidence suggesting it affects androgen levels, insulin sensitivity, or other metabolic factors relevant to PCOS. While some environmental chemicals can act as endocrine disruptors, perfluorinated compounds used as solvents in cosmetics have not been specifically linked to PCOS symptom exacerbation or hormonal interference in the context of topical skincare use. Women with PCOS can use products containing this ingredient without specific hormonal concerns. The primary considerations for PCOS relate to ingredients that directly affect hormones or inflammation, which does not apply to this solvent. From a PCOS management perspective, decafluoropentane is considered neutral.

General UseSAFE

Decafluoropentane and general use

Safe to Use

Decafluoropentane is used as a solvent and propellant in various cosmetic products, particularly aerosols. For the general population, it presents minimal immediate health risks from typical cosmetic use, with no significant irritation or allergic potential reported. The primary concerns surrounding perfluorinated compounds relate to environmental persistence and long-term bioaccumulation rather than acute toxicity. These chemicals break down very slowly in the environment and can accumulate in water systems and living organisms over time. Regulatory bodies are increasingly scrutinizing PFCs due to environmental concerns. The EU has implemented restrictions on certain perfluorinated compounds under REACH, and awareness of PFC impacts is growing. For consumers concerned about environmental impact and long-term exposure, choosing products without PFCs is an option, though the immediate health risk from cosmetic use remains low for most people.

Same profiles

Everything else flagged for the same profiles

Keep reading

Related ingredients

Ingredients that raise the same concerns.

Provenance

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on .

One ingredient is the easy case.

A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.

Download on theApp Store